Baek SB, Bahn G, Moon SJ, Lee J, Kim KH, Ko IG, et al
Situations requiring healthcare provider consultation: Frequent dose timing inconsistencies that suggest adherence challenges Concurrent illness affecting medication absorption or tolerance Addition of new medications that may interact with tirzepatide Persistent or worsening gastrointestinal symptoms Any uncertainty about appropriate dose timing Patients should be aware that tirzepatide may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying
Your injections or oral dose of Semaglutide (or any other GLP-1 agonist) will be used along with an individualized low-calorie, low-fat diet and exercise plan
For most healthy individuals, a 5 to 10 BPM increase in resting heart rate is not clinically dangerous
About 20% of users report flushing
Not every patient is a candidate for every medication